ESMO E-Learning and V-Learning
Watch E-Learning and V-Learning webcasts produced by leading oncology experts and take the CME test.
ESMO continually develops E-Learning and V-Learning modules covering a broad range of topics relevant for practising oncologists including:
- Recent discoveries and their impact on current treatments for diverse tumour types
- Oncology clinical case studies and conundrums
- Guidance on implementation of the latest ESMO clinical practise guidelines and incorporation of recent clinical advancements
- Selected oncology highlights from the past year
E-Learning and V-Learning modules less than 2 years are accompanied by a CME test (ESMO members only) awarding 1 ESMO-MORA category 1 point and 1 ACOE (Accreditation Council of Oncology in EU) CME credit on successful completion. ESMO members have the option to print the certificate immediately or store in the myESMO CME bank.
Modules marked as V-Learning contain video presentations to enhance your learning experience.
ESMO E-Learning and V-Learning Modules are the original property of ESMO. Authorship is retained by the module authors. The modules and their constituent slides can not be presented in any form, modified or otherwise, on a platform other than those belonging to ESMO, without prior explicit permission from ESMO. Module PDF files are available for individual download by medical professionals for study and reference purposes only.
|Non-Small-Cell Lung Cancer, Metastatic - Pathology/Molecular Biology - Translational Research||Important Pathways to Target in (Advanced) NSCLC: A Focus on ALK, EGFR-Inhibition and Anti-Angiogenesis and their Implications for Clinical Practice||Morena Fasano, Floriana Morgillo|
|Pathology/Molecular Biology - Translational Research||PI3K/Akt/mTOR Pathway||Massimo Broggini, Elisa Caiola|
|Anti-Cancer Agents & Biologic Therapy - Gastric Cancer||A Look to the Future in the Management of Metastatic and Locally Advanced Gastric Cancer||Michael Stahl|
|Breast Cancer - Pathology/Molecular Biology||Tumour Heterogeneity in Breast Cancer||Leticia De Mattos-Arruda|
|Anti-Cancer Agents & Biologic Therapy - Ovarian Cancer||Targeting Angiogenesis in Ovarian Cancer||Sandro Pignata, Sabrina Chiara Cecere|
|Cancer Aetiology, Epidemiology, Prevention||Smoking Cessation in the Oncology Population||Doron Sommer, Michael Gupta, Smriti Nayan|
|Anti-Cancer Agents & Biologic Therapy||The Value and Role of Anti-Angiogenesis in Solid Tumours and the Mechanism to Inhibit Angiogenesis||Valentina Gambardella, Fortunato Ciardiello, Erika Martinelli, Teresa Troiani|
|Anti-Cancer Agents & Biologic Therapy - Germ Cell Tumours - Supportive Care||Testicular Cancer: Treatment Strategies and Fertility Preservation||Giovanni Rosti, Andrea Garolla|
|Breast Cancer - Cancer Aetiology, Epidemiology, Prevention||Chemo-Endocrine Prevention of Breast Cancer||Andrea De Censi|
|Cancer in Adolescents - Cancer in Young Adults||Cancer in Adolescents and Young Adults||Giannis Mountzios, George Pentheroudakis, Daniel Stark|
|Anti-Cancer Agents & Biologic Therapy - Prostate Cancer||Emerging Treatments for Managing mCRPC Patients||Johann de Bono|
|Cancer Immunology and Immunotherapy - Lung and other Thoracic Tumours - Pathology/Molecular Biology||Future Directions in Clinical Research of NSCLC||Sanjay Popat|
|Melanoma and other Skin Tumours - Translational Research||V-Learning: Inhibition of MEK to Treat Cancer, focussing on Melanoma||James Larkin|
|Lung and other Thoracic Tumours - Translational Research||2013 Highlights in NSCLC||Niels Reinmuth, Martin Reck|
|Renal Cell Cancer||First-line Therapy for Renal Cell Carcinoma: Defining New Standards of Care from Phase III Trials||Joaquim Bellmunt|